Stockreport

VNRX: VolitionRx Reports 2023 Results; Distribution of Nu.Q Vet Test Expanding; Nu.Q Discover Growing; Two Key R&D Efforts in 2024/25: 1) Breakthrough Cancer Detection Method (Capture -PCR...

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com
PDF Commercialization of Nu.Q Vet Continues During 2023, Volition Veterinary (NYSE:VNRX) continued to expand its distribution network through new supply agreements. The [Read more]